Contract facts
UnrestrictedNo full NAICS 325413 intel page yet. Browse NAICS intelligence
Fecal Occult CPT is a federal Unrestricted award for 248-Network Contract Office 8 (36C248) held by Polymedco Cancer Diagnostic Products LLC. Estimated value $721K ($517K obligated). Current period of performance ends Sep 30, 2028. Last award drew 3 bidders. Place of performance: CORTLANDT MANOR NY. Related solicitation 36C24824Q0001.
Fecal occult cpt. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 30, 2028 (714 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 30, 2027.
Want the durability read on 36C24824P0031? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordPolymedco Cancer Diagnostic Products LLC — $13.0M obligated across 407 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24824P0031?
36C24824P0031 (Fecal occult CPT) is a 248-Network Contract Office 8 (36C248) award with a potential value of $721K, currently held by Polymedco Cancer Diagnostic Products LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C248-24-P-0031?
36C248-24-P-0031 is the dashed form of PIID 36C24824P0031 (Fecal occult CPT), held by Polymedco Cancer Diagnostic Products LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24824P0031?
248-Network Contract Office 8 (36C248) awarded 36C24824P0031 to Polymedco Cancer Diagnostic Products LLC (potential $721K).
Who is the incumbent on 36C24824P0031?
Polymedco Cancer Diagnostic Products LLC is the incumbent with $13.0M across 407 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2028.
When does Polymedco Cancer Diagnostic Products LLC’s 36C24824P0031 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24824P0031? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.